Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Sciomics logo — Protein and post-translational modification profiling for pr...

Sciomics

Protein and post-translational modification profiling for precision medicine

Founded 2013 Germany Germany 13 employees Biotechnology, Health Care

General Information

Company Name Sciomics
Founded Year 2013
Location Germany Germany
Founders / Decision Makers
Team member
Employees 13
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Sciomics. To contact Sciomics, visit sciomics.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sciomics compare?

A PDF of Sciomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sciomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sciomics

Protein profiling plays a crucial role in the advancement of biomedical research, enabling us to improve patients' quality of life by utilizing molecular signatures for accurate diagnosis and treatment. At Sciomics, our passion for advanced protein profiling is driving the future of Precision Medicine. We are continually expanding our biomarker signature pipeline to address a wide range of clinical indications and to advance Precision Diagnostics. Our cutting-edge services enable scientists worldwide to unravel the complexities of disease, uncover modes of action and identify promising protein biomarker candidates. Our service portfolio is anchored in our state-of-the-art scioDiscover microarray platform for protein and post-translational modification profiling. We are proud to support a wide range of research, from basic scientific discovery to breakthrough pharmaceutical initiatives (R&D). scioDiscover is a high-content, high-throughput system that provides a fast and cost-effective solution to your research needs. Its results are seamlessly translated into validation and clinical assays, enabling breakthrough biomarker discovery and preclinical drug development. Our team is dedicated to supporting you throughout your project: Project Planning: From planning to execution, we will help you navigate the most efficient route to achieve your research objectives. Technical Expertise: Our team provides unmatched proficiency in your proteomic analysis endeavors. Customized Solutions: We provide customized solutions to meet your specific research needs. Comprehensive Study Report: Our services include a comprehensive data analysis and a customized report. Our Platform Is Used For: • Protein Biomarker Identification and Verification • Novel Drug Target Discovery • Mode-of-Action Analysis • Pathway Activity Analysis • Disease Model Characterization, among other key applications Join us on our mission to revolutionize medicine! #PrecisionMedicine #Proteomics

No funding data available for Sciomics yet.

Sciomics Alternatives & Competitors

View All Alternatives
Sciomics vs
HTG Molecular Diagnostics
HTG Molecular Diagnostics United States

HTG is focused on advancing precision medicine

Post-IPO Equity
33 employees
Biotechnology, Health Care
Sciomics vs
Scailyte
Scailyte Switzerland

True precision medicine through single-cell science.

Series A
18 employees
AI, Biotechnology
Sciomics vs
Ionpath
Ionpath United States

Enabling precision medicine through high-definition spatial proteomics

Corporate Round
32 employees
Biotechnology, Health Care
View all alternatives

FAQ About Sciomics

Protein and post-translational modification profiling for precision medicine
Sciomics was founded in 2013.
Sciomics is headquartered in Germany.
Sciomics operates in Biotechnology and Health Care.
Sciomics has approximately 13 employees.
Top alternatives and competitors to Sciomics include HTG Molecular Diagnostics, Scailyte, Ionpath, Ayass BioScience, LLC, Apton Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sciomics and HTG Molecular Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sciomics, https://bouncewatch.com/company/sciomics, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes